Hypovitaminosis D is Associated with Endothelial Dysfunction in Patients with Metabolic Syndrome

Oruc C. U., Akpinar Y. E., Amikishiyev S., Uzum A. K., Salmaslioglu A., Gurdol F., ...Daha Fazla

CURRENT VASCULAR PHARMACOLOGY, cilt.15, sa.2, ss.152-157, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.2174/1570161114666161003093443
  • Dergi Adı: CURRENT VASCULAR PHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.152-157
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objectives: Recent research has shown that hypovitaminosis D may increase the risk of hypertension, vascular disease, diabetes mellitus, obesity and Metabolic Syndrome (MetS). Endothelial Dysfunction (ED) is one of the key components of MetS which is associated with an imbalance between vasoactive substances such as Nitric Oxide (NO) and Endothelins (ET). In this study, we assessed the association of 25(OH) D3 level with endothelial dysfunction and subclinical atherosclerosis in MetS patients.